![](/images/graphics-bg.png)
Pathfast Presepsin Assay for Early Diagnosis of Systemic Inflammatory Response Syndrome in Patients with Nephrolithiasis
المؤلفون المشاركون
Hou, Yan-song
Wang, Hua
Chen, Hao
Wu, Ling-feng
Lu, Lin-feng
He, Yi
المصدر
العدد
المجلد 2015، العدد 2015 (31 ديسمبر/كانون الأول 2015)، ص ص. 1-6، 6ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2015-02-04
دولة النشر
مصر
عدد الصفحات
6
التخصصات الرئيسية
الملخص EN
It is relatively difficult to diagnose bacterial sepsis in nephrolithiasis patients.
The aim of the study is to evaluate the diagnostic ability of presepsin in the differential diagnosis including SIRS, infection, or sepsis and to compare its diagnostic value with other markers, mainly as CRP, procalcitonin (PCT), and white blood cell (WBC) in patients of nephrolithiasis presenting with SIRS.
39 patients of nephrolithiasis who were diagnosed as SIRS were prospectively investigated.
Plasma presepsin was detected by Pathfast presepsin assay system; CRP and PCT were measured as well.
Additionally, 25 nephrolithiasis patients without SIRS were included.
At all timing samples, patients were classified as SIRS or non-SIRS group.
Median plasma presepsin levels were significantly increased in the SIRS group compared with non-SIRS group (452 pg/mL versus 178 ng/mL, P<0.001), and presepsin was markedly elevated even in the early stage of SIRS (584 pg/mL 6 h, 660 pg/mL 24 h versus 452 pg/mL, P<0.001).
According to the receiver-operating characteristic (ROC) analysis, presepsin demonstrated a high diagnostic value compared with either PCT or CRP.
In the early stage of SIRS, presepsin remained a highly sensitive (74.7%) and specific (88.4%) diagnostic marker compared with either PCT, CRP, or WBC.
Moreover, the areas under the curve (AUCs) of presepsin (84.6%) were also superior to those seen in either PCT (79.6%) or CRP (71.8%).
Thus plasma presepsin levels have comparable performance in SIRS for patients with nephrolithiasis.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Hou, Yan-song& Wang, Hua& Chen, Hao& Wu, Ling-feng& Lu, Lin-feng& He, Yi. 2015. Pathfast Presepsin Assay for Early Diagnosis of Systemic Inflammatory Response Syndrome in Patients with Nephrolithiasis. BioMed Research International،Vol. 2015, no. 2015, pp.1-6.
https://search.emarefa.net/detail/BIM-1056741
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Hou, Yan-song…[et al.]. Pathfast Presepsin Assay for Early Diagnosis of Systemic Inflammatory Response Syndrome in Patients with Nephrolithiasis. BioMed Research International No. 2015 (2015), pp.1-6.
https://search.emarefa.net/detail/BIM-1056741
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Hou, Yan-song& Wang, Hua& Chen, Hao& Wu, Ling-feng& Lu, Lin-feng& He, Yi. Pathfast Presepsin Assay for Early Diagnosis of Systemic Inflammatory Response Syndrome in Patients with Nephrolithiasis. BioMed Research International. 2015. Vol. 2015, no. 2015, pp.1-6.
https://search.emarefa.net/detail/BIM-1056741
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1056741
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)